© J. Poirier 2025-2026

Dr. Youla Tsantrizos, Ph.D., McGill University, Canada Dr. Tsantrizos is a well recognized medicinal chemist who has worked for more than 10 years as Group Leader for the Canadian medicinal chemistry program of Boehringer Ingelheim. She is now an assistant professor of Chemistry at McGill university where she has elaborated an Alzheimer therapeutic program in partnership with Dr. Judes Poirier. Dr. Henrik Zetterberg, Ph.D., Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Dr. Zetterberg has developed an extensive expertise in biomarkers research, neurochemistry and pathophysiological processes. Dr. Kaj Blennow, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Area of expertise: Alzheimer biomarkers, neurobiology of dementia, Dr. John Breitner, McGill University, Canada Founding Director of the PREVENT-AD Centre, Douglas Institute Montreal, Canada Areas of Expertise: Clinical drug trials and cognition  Dr. Sylvia Villeneuve, McGill University, Canada, Director of the PREVENT-AD Research Centre, Douglas Institute Montreal, Canada Areas of Expertise: MRI and PET imaging, neuropsychology, cognitive neuroscience Name Title Experience Anne Labonté  Reseach Assistant Laboratory Manager   Gabriel Aumont  B.Sc.  Ph.D. Student Isabel Sarty M.Sc.  Ph.D. student, IPN Julia Loncke B.Sc. M.Sc., student, IPN Mélissa Savard Analyst Senior Scientist Judes Poirier, Ph.D,C.Q    Director Co-Founder     Cynthia Picard  Associate Director Senior Scientist

Our Team Consultants and Advisors